Related Experiment Video
Updated: Aug 15, 2026
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
The relationship between plasma MHPG and NE: employing regression models in estimating centrally derived MHPG and
1Section on Anxiety and Affective Disorders, National Institute of Mental Health, Bethesda, Maryland, USA.
Abstract:
Studies investigating the role of the noradrenergic system in the pathophysiology of anxiety have focused on measuring plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) levels. Fewer studies have examined norepinephrine levels. Basal plasma norepinephrine and free MHPG levels were simultaneously measured in 33 normal controls and 20 panic disorder (PD) patients. Norepinephrine levels were similar in patients and controls, but MHPG levels were significantly lower in patients (13.34 +/- 3.22 vs 18.37 +/- 4.49 pmol ml-1, p < 0.0001). Norepinephrine correlated significantly with plasma MHPG levels in controls (r = 0.538, p < 0.0001) and patients (r = 0.645, p < 0.002). Patients had a trend toward a lower y-intercept than controls, suggesting a lower contribution by the CNS to MHPG pool plasma levels (9.18 vs 12.51, p < 0.08). Norepinephrine turnover rate was similar in patients and controls. We propose that the dysregulation in the noradrenergic system in PD may be akin to animal studies of acute-on-top-of-chronic stress paradigms, whereby chronic stress results in normal or decreased basal NE turnover and sensitized responses to recurrent stresses.
Insights
Panic disorder patients exhibit lower plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) levels, indicating potential noradrenergic system dysregulation. This finding suggests altered central nervous system contribution to MHPG levels in individuals with panic disorder.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- The noradrenergic system plays a crucial role in anxiety pathophysiology.
- Previous research primarily focused on plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) levels, with limited investigation into norepinephrine (NE).
Purpose of the Study:
- To simultaneously measure basal plasma norepinephrine and free MHPG levels in panic disorder (PD) patients and normal controls.
- To investigate potential differences in noradrenergic system activity between PD patients and healthy individuals.
Main Methods:
- Simultaneous measurement of basal plasma norepinephrine and free MHPG levels.
- Comparison of these levels between 33 normal controls and 20 PD patients.
- Correlation analysis between norepinephrine and MHPG levels in both groups.
Main Results:
- Plasma norepinephrine levels were similar between PD patients and controls.
- MHPG levels were significantly lower in PD patients compared to controls (13.34 vs 18.37 pmol/ml).
- A significant positive correlation between norepinephrine and MHPG levels was observed in both groups.
Conclusions:
- Panic disorder is associated with significantly lower plasma MHPG levels, suggesting noradrenergic system dysregulation.
- A trend towards a lower CNS contribution to plasma MHPG in PD patients indicates potential central alterations.
- The findings align with animal models of chronic stress, suggesting a similar neurobiological mechanism in PD.
More Related Videos
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
07:47A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver
Published on: May 19, 2026
